People: Guided Therapeutics Inc (GTHP.OB)
Dr. Mark L. Faupel, Ph.D., is President, Chief Executive Officer, Acting Chief Financial Officer, Director of Guided Therapeutics Inc. He has been a director since 2007 and has 25 years of experience in developing non-invasive alternatives to surgical biopsies and blood tests, especially in the area of cancer screening and diagnostics. Dr. Faupel has served as Chief Executive Officer since May 2007 and prior thereto was Chief Technical Officer from April 2001 to May 2007. He is Acting Chief Financial Officer as well. Prior to coming to the Company in 1998, Dr. Faupel was the co-founder and Vice President of Research and Development at Biofield Corp. His work in early stage cancer detection has won two international awards and he is a former member of the European School of Oncology Task Force. Dr. Faupel has served as a National Institutes of Health reviewer, is the inventor on 15 U.S. patents and has authored scientific publications and presentations, appearing in such peer-reviewed journals as The Lancet. Dr. Faupel earned his Ph.D. in neuroanatomy and physiology from the University of Georgia.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|